Symptoms of overdose clumsiness or unsteadiness, seizures, severe drowsiness, flushing or redness of face, hallucinations, muscle spasms (especially of neck and back), restlessness, shortness of breath, shuffling walk, tic-like (jerky) movements of head and face, trembling and shaking of hands, and insomnia.
A phenothiazine derivative that is used as an antipruritic.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Hydrocodone | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Alimemazine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Mirtazapine | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Orphenadrine | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Pramipexole | Alimemazine may increase the sedative activities of Pramipexole. |
| Ropinirole | Alimemazine may increase the sedative activities of Ropinirole. |
| Rotigotine | Alimemazine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Alimemazine. |
| Sodium oxybate | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Thalidomide | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Alimemazine may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Alimemazine is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Alimemazine is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Alimemazine. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Alimemazine. |
| Sulpiride | Alimemazine may increase the antipsychotic activities of Sulpiride. |
| Benzylpenicilloyl polylysine | Alimemazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with Alimemazine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Alimemazine. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Alimemazine. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Alimemazine. |
| Mequitazine | Alimemazine may increase the arrhythmogenic activities of Mequitazine. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Tetrabenazine. |
| Deutetrabenazine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Deutetrabenazine. |
| Thiopental | The risk or severity of adverse effects can be increased when Alimemazine is combined with Thiopental. |
| Metyrosine | The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Alimemazine. |
| Ethanol | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Alimemazine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Fluvoxamine. |
| Duloxetine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Alimemazine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Alimemazine is combined with Nefazodone. |
| Zimelidine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Dapoxetine. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Alimemazine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Alimemazine is combined with Alaproclate. |
| Citalopram | The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Citalopram. |
| Escitalopram | The risk or severity of adverse effects can be increased when Alimemazine is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Alimemazine is combined with Milnacipran. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Alimemazine. |
| Amphetamine | Amphetamine may decrease the sedative activities of Alimemazine. |
| Phentermine | Phentermine may decrease the sedative activities of Alimemazine. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of Alimemazine. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of Alimemazine. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of Alimemazine. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of Alimemazine. |
| Mephentermine | Mephentermine may decrease the sedative activities of Alimemazine. |
| MMDA | MMDA may decrease the sedative activities of Alimemazine. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of Alimemazine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Alimemazine. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Alimemazine. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of Alimemazine. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of Alimemazine. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of Alimemazine. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of Alimemazine. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of Alimemazine. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of Alimemazine. |
| Ritobegron | Ritobegron may decrease the sedative activities of Alimemazine. |
| Mephedrone | Mephedrone may decrease the sedative activities of Alimemazine. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of Alimemazine. |
| Gepefrine | Gepefrine may decrease the sedative activities of Alimemazine. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of Alimemazine. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of Alimemazine. |
| Esmolol | The serum concentration of Esmolol can be increased when it is combined with Alimemazine. |
| Betaxolol | The serum concentration of Betaxolol can be increased when it is combined with Alimemazine. |
| Metoprolol | The serum concentration of Metoprolol can be increased when it is combined with Alimemazine. |
| Atenolol | The serum concentration of Atenolol can be increased when it is combined with Alimemazine. |
| Timolol | The serum concentration of Timolol can be increased when it is combined with Alimemazine. |
| Propranolol | The serum concentration of Propranolol can be increased when it is combined with Alimemazine. |
| Labetalol | The serum concentration of Labetalol can be increased when it is combined with Alimemazine. |
| Bisoprolol | The serum concentration of Bisoprolol can be increased when it is combined with Alimemazine. |
| Alprenolol | The serum concentration of Alprenolol can be increased when it is combined with Alimemazine. |
| Pindolol | The serum concentration of Pindolol can be increased when it is combined with Alimemazine. |
| Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Alimemazine. |
| Propafenone | The serum concentration of Propafenone can be increased when it is combined with Alimemazine. |
| Acebutolol | The serum concentration of Acebutolol can be increased when it is combined with Alimemazine. |
| Nadolol | The serum concentration of Nadolol can be increased when it is combined with Alimemazine. |
| Bevantolol | The serum concentration of Bevantolol can be increased when it is combined with Alimemazine. |
| Practolol | The serum concentration of Practolol can be increased when it is combined with Alimemazine. |
| Penbutolol | The serum concentration of Penbutolol can be increased when it is combined with Alimemazine. |
| Oxprenolol | The serum concentration of Oxprenolol can be increased when it is combined with Alimemazine. |
| Dexpropranolol | The serum concentration of Dexpropranolol can be increased when it is combined with Alimemazine. |